Company Short-Term Debts: GRI Bio Corp (GRI)

Public company logo of GRI Bio, Inc. (GRI)

GRI Bio, Inc. (GRI) is implementing sustainable standards in biochemistry while strictly adhering to ethics and data confidentiality. Patent protection for its unique liver fibrosis platform shields the business from predatory pricing. This price chart on GURU.Markets shows a value of 0.00, illustrating the asset's price action. GRI Bio, Inc. (GRI) leverages cellular science to develop advanced immune correction methods aimed at eliminating inflammatory processes.

Company Short-Term Loans and Borrowings: gribio.com (GRI) for 02/21/2024 - 10/28/2026

GRI Bio Corporation - analytical breakdowns and key metrics (GRI)

- price and consensus price forecast:
Price Chart GRI Bio|GRI - Consensus Target
- market capitalization data:
Market Capitalization GRI Bio, Inc.|GRI - Enterprise Value
- book capitalization data:
Accounting Value per Share GRI Bio|GRI - Accounting Value of Company|Market Capitalization to Book Value Ratio gribio.com|GRI - Company Total Asset Base
- debt and liquidity data:
Debt to Equity GRI Bio, Inc.|GRI - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity GRI Bio, Inc.|GRI - Company Total Debt|Debt to Book Value GRI Bio, Inc.|GRI - Company Long-Term Debts|Company Short-Term Debt GRI Bio
Initial company analysis:GRI Bio (GRI)
Flagship merchandise of GRI Bio, Inc.

Investors must identify clear liquidity markers within financial statements to assess business resilience. This indicator captures the total credit obligations maturing within twelve months; therefore, analyzing the current liabilities of GRI Bio, Inc. allows for an assessment of whether the company has sufficient resources to fund its unique fibrosis research without risking its operational independence.

Competitor analysis for GRI Bio, Inc.

ARGX: Company Short-Term Debt|BNTX - Company Current Liabilities|ABVX: Company Short-Term Debts|Company Short-Term Debts ADMA Corp|PTGX - Company Current Liabilities|Company Short-Term Loans and Borrowings immunovant.com|KNSA (Kiniksa) - Company Short-Term Debts|Short-Term Debt Volume GRFS (Grifols SA)|Adaptive Biotechnologies Corp - Company Short-Term Debt|Celldex Corp - Company Current Liabilities|AUPH: Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|VERA: Company Current Liabilities|DNTH (Dianthus Therapeutics Inc) - Company Short-Term Debts|Company Short-Term Debt Pharvaris Corp (PHVS)|Company Short-Term Indebtedness abcellera.com|Tourmaline Bio, Inc. - Company Short-Term Debts|Short-Term Debt precigen.com (PGEN)|PHAR (Pharming Group) - Company Short-Term Debts|Nektar Therapeutics Inc - Short-Term Indebtedness|Company Short-Term Debt Upstream Bio Corp (UPB)|ZBIO - Company Short-Term Loans and Borrowings|Immunome, Inc. - Company Short-Term Debts|Short-Term Debt Volume gossamerbio.com|KALV - Company Current Liabilities|Company Short-Term Loans and Borrowings Septerna, Inc.|Company Short-Term Debts Pieris Pharmaceuticals Inc (PVLA)|Company Short-Term Debt Savara Pharma (SVRA)|Company Short-Term Debts RIGL|anaptysbio.com - Short-Term Debt Volume|ATXS (Astria Therapeutics, Inc.) - Company Short-Term Debt|enGene Holdings Inc (ENGN) - Short-Term Debt|Company Current Liabilities RAPT Therapeutics RAPT|Aerovate Therapeutics (JBIO) - Company Short-Term Loans and Borrowings|ACRS: Company Short-Term Debts|Short-Term Debt Volume KYTX|Company Short-Term Debt Tiziana Life Sciences Ltd TLSA|Company Short-Term Indebtedness Cabaletta Bio Inc. (CABA)|Ventyx Bio - Company Short-Term Debts|THTX - Company Current Liabilities|Company Current Liabilities AVTX (Avalo Therapeutics, Inc)|ELDN - Short-Term Debt Volume|Company Short-Term Debts AGEN (Agenus Inc.)|CLYM (Climb Bio Inc.) - Short-Term Indebtedness|ZURA - Company Short-Term Debt|Company Short-Term Loans and Borrowings aTyr Pharmaceuticals|ADAG (Adagene) - Company Short-Term Debts|Short-Term Debt Volume IMA (ikenaoncology.com)|Shattuck Labs (STTK) - Company Short-Term Debt|Current Liabilities Equillium Inc EQ|Company Short-Term Debts Connect Pharma (CNTB)|IMUX - Company Short-Term Loans and Borrowings|ATRA: Company Short-Term Debts|IFRX (InflaRx) - Company Short-Term Debts|XFOR - Company Short-Term Debt|Company Short-Term Loans and Borrowings ACET|Company Short-Term Debt CELU (Celularity Inc.)|Company Current Liabilities INmune Bio Corporation (INMB)|Company Short-Term Debts BRNS (Barinthus Biotherapeutics)|KZR - Company Short-Term Debts|Company Current Liabilities SAB Biotherapeutics, Inc. (SABS)|AKTX - Company Short-Term Loans and Borrowings|enlivex.com - Company Short-Term Debts|QTTB (Q32 Bio) - Short-Term Debt Volume|Company Short-Term Debt GOVX|Company Current Liabilities EDSA|Company Short-Term Debt IBIO (iBio)|Company Current Liabilities carismatx.com CARM|Company Current Liabilities XTLB (XTL Biopharmaceuticals, Ltd.)|Bolt Biotherapeutics Inc. - Company Short-Term Debts|HCW Biologics Inc (HCWB) - Company Short-Term Debt|APVO - Company Short-Term Indebtedness|Company Short-Term Debts AIM|Aditxt, Inc. (ADTX) - Short-Term Debt|XORTX - Company Short-Term Debts|Short-Term Indebtedness HIND|Revelation Biosciences (REVB) - Company Short-Term Debt|Company Short-Term Loans and Borrowings indaptusrx.com (INDP)|Company Short-Term Debts SCNI|CALI - Short-Term Debt Volume|Company Current Liabilities Affimed Therapeutics (AFMD)|ALLK - Company Short-Term Loans and Borrowings|hookipapharma.com (HOOK) - Company Short-Term Debts|IGM Biosciences (IGMS) - Company Short-Term Debt|ITOS: Company Short-Term Debts|Short-Term Debt Volume OCEA|TC BioPharm (Holdings) PLC - Company Short-Term Debt|Short-Term Debt Third Harmonic Bio Inc THRD